PRICE T ROWE ASSOCIATES INC /MD/ - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 140 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$54,476
-28.1%
2,715,599
+1.2%
0.01%
-27.3%
Q2 2023$75,726
+100.1%
2,684,352
+22.0%
0.01%
+83.3%
Q1 2023$37,844
-13.7%
2,200,169
+1.1%
0.01%
-14.3%
Q4 2022$43,839
-99.9%
2,176,700
-1.9%
0.01%
-12.5%
Q3 2022$48,037,000
-60.2%
2,217,740
-48.4%
0.01%
-46.7%
Q2 2022$120,789,000
-37.6%
4,298,551
+2.4%
0.02%
-25.0%
Q1 2022$193,704,000
-47.4%
4,198,180
-4.2%
0.02%
-39.4%
Q4 2021$368,425,000
+48.2%
4,382,881
+17.5%
0.03%
+43.5%
Q3 2021$248,596,000
+43.4%
3,730,425
+14.4%
0.02%
+43.8%
Q2 2021$173,409,000
+268.6%
3,259,568
+200.6%
0.02%
+220.0%
Q1 2021$47,045,000
-17.2%
1,084,246
-0.9%
0.01%
-16.7%
Q4 2020$56,824,000
+57.2%
1,094,026
-1.1%
0.01%
+50.0%
Q3 2020$36,156,000
-36.6%
1,106,020
-6.9%
0.00%
-42.9%
Q2 2020$57,027,0001,187,5660.01%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 2,099,583$42,117,63514.06%
Mayo Clinic 187,143$3,754,0897.23%
Matrix Capital Management Company, LP 13,959,973$280,037,0583.36%
5AM Venture Management, LLC 490,000$9,829,4002.83%
Eventide Asset Management 7,814,039$156,749,6222.82%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 961,486$19,287,4102.70%
Avidity Partners Management LP 2,100,000$42,126,0001.70%
First Light Asset Management, LLC 848,477$17,020,4491.62%
Sofinnova Investments, Inc. 1,211,641$24,305,5181.53%
SECTORAL ASSET MANAGEMENT INC 386,525$7,753,6921.51%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders